Article Information
History
- July 17, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Sebastian Weis1,2,3,
- André Scherag4,
- Michael Baier5,
- Michael Kiehntopf6,
- Thomas Kamradt7,
- Steffi Kolanos1,
- Juliane Ankert1,
- Stefan Glöckner5,
- Oliwia Makarewicz1,
- Stefan Hagel1,
- Christina Bahrs1,8,
- Aurelia Kimmig1,
- Hans Proquitté9,
- Joel Guerra1,2,
- Bettina Löffler5,
- Mathias W. Pletz1,*,
- CoNAN study group.
- 1Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
- 2Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany
- 3Department of Anesthesiology and Intensive Care, Jena University Hospital, Jena, Germany
- 4Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital, Jena, Germany
- 5Institute of Medical Microbiology, Jena University Hospital, Jena, Germany
- 6Institute of Clinical Chemistry and Laboratory Diagnostics and Integrated Biobank Jena (IBBJ), Jena University Hospital, Jena, Germany
- 7Institute of Immunology, Jena University Hospital, Jena, Germany
- 8Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria
- 9Children’s Hospital, Jena University Hospital, Jena, Germany
- ↵*Corresponding Author: Mathias W. Pletz, MD, Sebastian Weis, MD, Institute for Infectious Diseases and Infection Control, Am Klinikum 1, Jena University Hospital 07747 Jena, Germany, Tel: +49.3641.9-324794, Fax: +49.3641.9-324652, Mail: Mathias.Pletz{at}med.uni-jena.de; Sebastian.Weis{at}med.uni-jena.de
Posted July 17, 2020.
Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study
